• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients.在印度患者中，与蛋白酶抑制剂治疗失败相关的HIV-1 C亚型中，新型四肽插入Gag-p6 ALIX结合基序。
AIDS. 2014 Sep 24;28(15):2319-22. doi: 10.1097/QAD.0000000000000419.
2
HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness.HIV-1 亚型 C 带有 PYxE 插入，增强了 Gag-p6 与宿主细胞蛋白 ALIX 的结合，并提高了复制适应性。
J Virol. 2019 Apr 17;93(9). doi: 10.1128/JVI.00077-19. Print 2019 May 1.
3
Mutational Heterogeneity in p6 Gag Late Assembly (L) Domains in HIV-1 Subtype C Viruses from South Africa.南非HIV-1 C亚型病毒p6 Gag晚期组装（L）结构域的突变异质性
AIDS Res Hum Retroviruses. 2016 Jan;32(1):80-4. doi: 10.1089/AID.2015.0266. Epub 2015 Oct 9.
4
The PTAP sequence duplication in HIV-1 subtype C Gag p6 in drug-naive subjects of India and South Africa.印度和南非未接受过抗逆转录病毒治疗的HIV-1 C亚型Gag p6蛋白中PTAP序列重复情况
BMC Infect Dis. 2017 Jan 24;17(1):95. doi: 10.1186/s12879-017-2184-4.
5
Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa.在 Gag-p6 中 PYxE 插入的进化后，复制能力增强与东非 HIV-1 亚型 C 的毒力增强相关。
J Med Virol. 2017 Jan;89(1):106-111. doi: 10.1002/jmv.24610. Epub 2016 Jul 6.
6
PYRE insertion within HIV-1 subtype C p6-Gag functions as an ALIX-dependent late domain.PYRE 插入 HIV-1 亚型 C p6-Gag 中充当依赖 ALIX 的晚期结构域。
Sci Rep. 2018 Jun 11;8(1):8917. doi: 10.1038/s41598-018-27162-1.
7
Genetic Changes in HIV-1 Gag-Protease Associated with Protease Inhibitor-Based Therapy Failure in Pediatric Patients.与基于蛋白酶抑制剂的治疗失败相关的儿童患者HIV-1 Gag蛋白酶的基因变化
AIDS Res Hum Retroviruses. 2015 Aug;31(8):776-82. doi: 10.1089/AID.2014.0349. Epub 2015 Jun 4.
8
Role of Gag mutations in PI resistance in the Swiss HIV cohort study: bystanders or contributors?瑞士HIV队列研究中Gag突变在蛋白酶抑制剂耐药性中的作用：旁观者还是促成因素？
J Antimicrob Chemother. 2017 Mar 1;72(3):866-875. doi: 10.1093/jac/dkw493.
9
Impact of HIV type 1 protease, reverse transcriptase, cleavage site, and p6 mutations on the virological response to quadruple therapy with saquinavir, ritonavir, and two nucleoside analogs.1型人类免疫缺陷病毒蛋白酶、逆转录酶、切割位点及p6突变对沙奎那韦、利托那韦与两种核苷类似物四联疗法病毒学应答的影响
AIDS Res Hum Retroviruses. 2001 Apr 10;17(6):487-97. doi: 10.1089/08892220151126526.
10
Genetic determinants in HIV-1 Gag and Env V3 are related to viral response to combination antiretroviral therapy with a protease inhibitor.HIV-1 群特异性抗原（Gag）和包膜蛋白V3区（Env V3）的遗传决定因素与病毒对蛋白酶抑制剂联合抗逆转录病毒治疗的反应有关。
AIDS. 2009 Aug 24;23(13):1631-40. doi: 10.1097/QAD.0b013e32832e0599.

引用本文的文献

1
Construction of a Macrophage-Tropic Subtype C HIV-1-mGreenLantern Reporter Virus for Studies on HIV-1 Replication and the Impact of Methamphetamine.构建用于研究HIV-1复制及甲基苯丙胺影响的巨噬细胞嗜性C型HIV-1-mGreenLantern报告病毒
Viruses. 2024 Nov 29;16(12):1859. doi: 10.3390/v16121859.
2
Importance of Viral Late Domains in Budding and Release of Enveloped RNA Viruses.病毒晚期结构域在有包膜 RNA 病毒出芽和释放中的重要性。
Viruses. 2021 Aug 6;13(8):1559. doi: 10.3390/v13081559.
3
Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage.细胞毒性淋巴细胞通过颗粒酶 M 介导的裂解靶向 HIV-1 Gag。
Front Immunol. 2021 Apr 19;12:669347. doi: 10.3389/fimmu.2021.669347. eCollection 2021.
4
HIV-1 Sequences from Ugandan Early Infections Reveal Sequence Variants Associated with Elevated Replication Capacity.来自乌干达早期感染者的 HIV-1 序列显示与高复制能力相关的序列变异。
Viruses. 2021 Jan 23;13(2):171. doi: 10.3390/v13020171.
5
A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort.在埃塞俄比亚首个全国性 HIV 队列中，对一线抗逆转录病毒治疗失败的患者进行病毒全基因组关联研究和基因型耐药性检测。
BMC Infect Dis. 2019 Jul 1;19(1):569. doi: 10.1186/s12879-019-4196-8.
6
CCL2 mobilizes ALIX to facilitate Gag-p6 mediated HIV-1 virion release.CCL2 募集 ALIX 以促进 Gag-p6 介导的 HIV-1 病毒粒子释放。
Elife. 2019 Jun 7;8:e35546. doi: 10.7554/eLife.35546.
7
HIV-1 Subtype C with PYxE Insertion Has Enhanced Binding of Gag-p6 to Host Cell Protein ALIX and Increased Replication Fitness.HIV-1 亚型 C 带有 PYxE 插入，增强了 Gag-p6 与宿主细胞蛋白 ALIX 的结合，并提高了复制适应性。
J Virol. 2019 Apr 17;93(9). doi: 10.1128/JVI.00077-19. Print 2019 May 1.
8
PYRE insertion within HIV-1 subtype C p6-Gag functions as an ALIX-dependent late domain.PYRE 插入 HIV-1 亚型 C p6-Gag 中充当依赖 ALIX 的晚期结构域。
Sci Rep. 2018 Jun 11;8(1):8917. doi: 10.1038/s41598-018-27162-1.
9
Prediction of coreceptor usage by five bioinformatics tools in a large Ethiopian HIV-1 subtype C cohort.在一个大型埃塞俄比亚HIV-1 C亚型队列中，使用五种生物信息学工具预测共受体使用情况。
PLoS One. 2017 Aug 25;12(8):e0182384. doi: 10.1371/journal.pone.0182384. eCollection 2017.
10
Monophylogenetic HIV-1C epidemic in Ethiopia is dominated by CCR5-tropic viruses-an analysis of a prospective country-wide cohort.埃塞俄比亚单一系统发生的HIV-1C流行以CCR5嗜性病毒为主——一项前瞻性全国队列分析
BMC Infect Dis. 2017 Jan 6;17(1):37. doi: 10.1186/s12879-016-2163-1.

本文引用的文献

1
Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades.瑞典HIV-1流行的时间趋势：三十多年来非B亚型和重组形式的增加。
PLoS One. 2014 Jun 12;9(6):e99390. doi: 10.1371/journal.pone.0099390. eCollection 2014.
2
Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India.药物不良反应对治疗成功的影响：对印度开始一线抗逆转录病毒治疗的HIV感染者的前瞻性队列分析。
PLoS One. 2014 Mar 10;9(3):e91028. doi: 10.1371/journal.pone.0091028. eCollection 2014.
3
Pattern of microbial translocation in patients living with HIV-1 from Vietnam, Ethiopia and Sweden.
J Int AIDS Soc. 2014 Jan 24;17(1):18841. doi: 10.7448/IAS.17.1.18841. eCollection 2014.
4
Update of the drug resistance mutations in HIV-1: March 2013.2013年3月HIV-1耐药性突变的更新情况
Top Antivir Med. 2013 Feb-Mar;21(1):6-14.
5
Natural deletion of L35Y36 in p6 gag eliminate LYPXnL/ALIX auxiliary virus release pathway in HIV-1 subtype C.HIV-1 亚型 C 中 p6 gag 中 L35Y36 的自然缺失消除了 LYPXnL/ALIX 辅助病毒释放途径。
Virus Res. 2012 Dec;170(1-2):154-8. doi: 10.1016/j.virusres.2012.08.020. Epub 2012 Sep 4.
6
Human Immunodeficiency Virus Gag and protease: partners in resistance.人类免疫缺陷病毒 Gag 和蛋白酶：耐药的伙伴。
Retrovirology. 2012 Aug 6;9:63. doi: 10.1186/1742-4690-9-63.
7
Epidemiology of transmitted drug resistance in chronically HIV-infected patients in Germany: the RESINA study 2001-2009.德国慢性 HIV 感染患者传播耐药性的流行病学：RESINA 研究 2001-2009。
Intervirology. 2012;55(2):154-9. doi: 10.1159/000332015. Epub 2012 Jan 24.
8
Transmitted drug resistance and phylogenetic analysis of HIV CRF01_AE in Northern Vietnam.越南北部 HIV CRF01_AE 的传播耐药性和系统进化分析。
Infect Genet Evol. 2012 Mar;12(2):448-52. doi: 10.1016/j.meegid.2011.04.034. Epub 2011 May 19.
9
Characterization of HIV type 1 subtype C protease gene: selection of L63P mutation in protease inhibitor-naive Indian patients.1型人类免疫缺陷病毒C亚型蛋白酶基因的特征分析：在未接受蛋白酶抑制剂治疗的印度患者中L63P突变的选择
AIDS Res Hum Retroviruses. 2011 Nov;27(11):1249-53. doi: 10.1089/AID.2011.0078. Epub 2011 May 9.
10
Accumulation of P(T/S)AP late domain duplications in HIV type 1 subtypes B, C, and F derived from individuals failing ARV therapy and ARV drug-naive patients.源自接受抗逆转录病毒治疗失败个体及未接受过抗逆转录病毒治疗患者的1型人类免疫缺陷病毒B、C和F亚型中P(T/S)AP晚期结构域重复序列的积累。
AIDS Res Hum Retroviruses. 2011 Jun;27(6):687-92. doi: 10.1089/aid.2010.0282. Epub 2011 Jan 23.

在印度患者中，与蛋白酶抑制剂治疗失败相关的HIV-1 C亚型中，新型四肽插入Gag-p6 ALIX结合基序。

Novel tetra-peptide insertion in Gag-p6 ALIX-binding motif in HIV-1 subtype C associated with protease inhibitor failure in Indian patients.

作者信息

Neogi Ujjwal, Rao Shwetha D, Bontell Irene, Verheyen Jens, Rao Vasudev R, Gore Sagar C, Soni Neelesh, Shet Anita, Schülter Eugen, Ekstrand Maria L, Wondwossen Amogne, Kaiser Rolf, Madhusudhan Mallur S, Prasad Vinayaka R, Sonnerborg Anders

机构信息

aDivision of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden bDivision of Public Health and Infection, St. John's Research Institute, Bangalore India cUnit of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden dInstitute of Virology, University-Hospital, University Duisburg-Essen, Essen, Germany eDepartment of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA fIndian Institute of Science Education and Research, Pune, Maharashtra, India gInstitute of Virology, University of Cologne, Cologne, Germany hDepartment of Medicine, University of California, San Francisco, California, USA iDepartment of Medicine, Faculty of Medicine, Addis Ababa University, Addis Ababa, Ethiopia jBioinformatics Institute kDepartment of Biological Sciences, National University of Singapore, Singapore.

出版信息

AIDS. 2014 Sep 24;28(15):2319-22. doi: 10.1097/QAD.0000000000000419.

DOI:10.1097/QAD.0000000000000419
PMID:25102091
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4198440/
Abstract

A novel tetra-peptide insertion was identified in Gag-p6 ALIX-binding region, which appeared in protease inhibitor failure Indian HIV-1C sequences (odds ratio=17.1, P < 0.001) but was naturally present in half of untreated Ethiopian HIV-1C sequences. The insertion is predicted to restore ALIX-mediated virus release pathway, which is lacking in HIV-1C. The clinical importance of the insertion needs to be evaluated in HIV-1C dominating regions wherein the use of protease inhibitor drugs are being scaled up.

摘要

在Gag-p6 ALIX结合区域发现了一种新的四肽插入，它出现在蛋白酶抑制剂治疗失败的印度HIV-1C序列中（优势比=17.1，P<0.001），但在一半未经治疗的埃塞俄比亚HIV-1C序列中自然存在。预计该插入可恢复HIV-1C中缺乏的ALIX介导的病毒释放途径。在蛋白酶抑制剂药物使用正在扩大的HIV-1C主导地区，需要评估该插入的临床重要性。